by jlohrconsulting | Sep 12, 2025 | Uncategorized
Diabetes Metab J. 2025 Sep;49(5):934-950. doi: 10.4093/dmj.2025.0561. Epub 2025 Sep 1. ABSTRACT The global prevalence of early-onset type 2 diabetes (EOT2D) is rising rapidly. Adults with EOT2D represent a high-risk population characterised by increased rates of...
by jlohrconsulting | Sep 12, 2025 | Uncategorized
Commun Biol. 2025 Sep 11;8(1):1342. doi: 10.1038/s42003-025-08824-z. ABSTRACT Environmental lead (Pb) exposure has been implicated in the development of depression. Here we show that Pb induces depression-like behaviour in mice by triggering ferroptosis. Single-cell...
by jlohrconsulting | Sep 12, 2025 | Uncategorized
Neuropsychopharmacology. 2025 Sep 11. doi: 10.1038/s41386-025-02229-6. Online ahead of print. ABSTRACT Motor signs are common in patients with a major depressive disorder (MDD) and associated with functional disability and falls. They appear to be more pronounced in...
by jlohrconsulting | Sep 12, 2025 | Uncategorized
Support Care Cancer. 2025 Sep 12;33(10):847. doi: 10.1007/s00520-025-09906-8. ABSTRACT OBJECTIVE: This study aimed to explore the effect of nursing intervention based on the broaden-and-build theory on the psychosocial adaptability of patients with minimally invasive...
by jlohrconsulting | Sep 12, 2025 | Uncategorized
MMW Fortschr Med. 2025 Sep;167(15):60-62. doi: 10.1007/s15006-025-5202-2. ABSTRACT The prevalence of depression, including adjustment disorders, in palliative care ranges from 20% to 40%. Depressive symptoms are often not reported spontaneously and must be classified...
Recent Comments